Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728694 | SCV000856299 | uncertain significance | not provided | 2017-08-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000728694 | SCV001813995 | uncertain significance | not provided | 2020-09-17 | criteria provided, single submitter | clinical testing | Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002535085 | SCV003527865 | uncertain significance | Inborn genetic diseases | 2022-01-31 | criteria provided, single submitter | clinical testing | The c.952C>T (p.P318S) alteration is located in exon 9 (coding exon 9) of the TRMU gene. This alteration results from a C to T substitution at nucleotide position 952, causing the proline (P) at amino acid position 318 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001830600 | SCV002076162 | uncertain significance | Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins | 2019-11-11 | no assertion criteria provided | clinical testing |